Ground Swell Capital’s VanEck Pharmaceutical ETF PPH Stock Holding History

Ground Swell Capital’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,445	Closed	-$1.6M	–	204
2026 Q1	$1.6M	Buy	+15,445	New	+$1.65M	3.17%	3

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Ground Swell Capital's PPH Position: Q2 2026 in Review

Ground Swell Capital sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2026, closing a stake of 15,445 shares — an estimated $1.6M sold.

Ground Swell Capital first reported a position in PPH in Q1 2026 and held it in 1 quarter. The position peaked at $1.6M in Q1 2026. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Ground Swell Capital reported no remaining VanEck Pharmaceutical ETF position as of Q2 2026 after selling out during the quarter.
Ground Swell Capital sold 15,445 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $1.6M.
Ground Swell Capital first reported a position in VanEck Pharmaceutical ETF in Q1 2026 and held it in 1 quarter.
Ground Swell Capital's VanEck Pharmaceutical ETF position peaked at $1.6M in Q1 2026.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Ground Swell Capital's 13F filing for Q2 2026, filed 5 Aug 2026.